Pathogenesis of Pediatric Obsessive-compulsive Disorder: Based on the Microbiota-gut-brain Axis
Condition(s) studied
Study summary
This study aims to investigate the characteristics of the microbiota-gut-brain axis in pediatric patients with obsessive-compulsive disorder (OCD) through performing an integrated analysis of gut microbiota, serum metabolomics, neuroimaging and electroencephalography (EEG), conducted before and after treatment with selective serotonin reuptake inhibitors (SSRIs). The results will be compared with those of pediatric OCD paitents comorbid with tic disorder (TD) and healthy controls. The findings are expected to further elucidate the potential pathogenesis of OCD, providing a theoretical basis for identifying novel clinical intervention targets and optimizing treatment strategies.
Eligibility
Primary outcome measure(s)
- Changes in the diversity and composition of the microbiome before and after drug treatment. — Before and after treatment with SSRIs for 12 weeks
The diversity (including alpha-diversity and beta-diversity) and composition will be measured in OCD patients and OCD patients with TD before and after drug treatment, and the results will be compared with those of healthy controls.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Shanghai Mental Health Center | Shanghai | Shanghai Municipality | Recruiting |
More Shanghai Mental Health Center trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06754319 on ClinicalTrials.gov ↗ ← All trials in China